Fundraising Fox

Avedro

Waltham, US · Delaware corporation · 5 known investors

avedro.com ↗

Glaukos develops surgical and pharmaceutical therapies for ophthalmic diseases including glaucoma, corneal health, and retinal disease. The company designs platform technologies to serve ophthalmologists and patients, with a pipeline of 14+ clinical candidates across glaucoma, corneal, and retinal indications.

BiotechHealthtechMedical Devicesin /glaukos-corporation@GlaukosCorp

Founders & leadership

JH
Jason HongDirector
DF
David F. MullerExecutive Officer, Director
JD
Jeff DykanDirector
AN
Anthony NataleDirector
RP
Robert PalmisanoDirector
PJ
Philip J. FerneauDirector
MC
M. Carl Johnson, IIIDirector
DB
David BerryDirector
MB
Michael BighamDirector
BJ
Brian J. RobertsExecutive Officer
JM
Joseph MandatoDirector

Investors · 5

APERTURE Venture PartnersBoston · $1M – $5M
LAVHong Kong · $5M – $15M
Lilly Asia VenturesHong Kongvia Hongbo Lu · board
SCP Vitalife PartnersTel Aviv · $3M – $7Mvia Jeff Dykan · board
Third Point VenturesMenlo Park

Reported raises · per SEC filings

Form D private placements
▶$25MraisedMay 2018 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SilversteinDirector
  • Gilbert KlimanDirector
  • Garheng KongDirector
  • Reza ZadnoExecutive Officer, Director
  • Robert PalmisanoDirector
  • Hongbo LuDirector
  • Joseph MandatoDirector
  • Donald ZurbayDirector
Offering amount
$25M
Amount sold
$25M
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedMay 2017 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • REZA ZADNOExecutive Officer, Director
  • PAUL BAVIERExecutive Officer
  • GILBERT H. KLIMANDirector
  • JOSEPH MANDATODirector
  • JONATHAN SILVERSTEINDirector
  • TOM GRIFFINExecutive Officer
  • ROBERT PALMISANODirector
Offering amount
$12M
Amount sold
$12M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.5MraisedNov 2015 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve BlinnExecutive Officer
  • David F. MullerExecutive Officer, Director
  • Jeff DykanDirector
  • M. Carl Johnson, IIIDirector
  • Brian J. RobertsExecutive Officer
  • Anthony NataleDirector
  • Robert PalmisanoDirector
  • Joseph MandatoDirector
  • Philip J. FerneauDirector
Offering amount
$32M
Amount sold
$16.5M
First sale
Nov 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.7MraisedApr 2015 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason HongDirector
  • David F. MullerExecutive Officer, Director
  • Jeff DykanDirector
  • Anthony NataleDirector
  • Robert PalmisanoDirector
  • Philip J. FerneauDirector
  • M. Carl Johnson, IIIDirector
  • David BerryDirector
  • Michael BighamDirector
  • Brian J. RobertsExecutive Officer
  • Joseph MandatoDirector
Offering amount
$17.6M
Amount sold
$13.7M
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.